Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Kamada Ltd. is a global, vertically integrated biopharmaceutical company with a portfolio of marketed, plasma-derived therapies, a robust late-stage PDUFA-post marketing pipeline and proprietary protein engineering and platform technology. The Company is focused on plasma-derived protein therapeutics for orphan indications and has a commercial presence in more than 30 countries. Kamada develops, produces, and markets these biopharmaceutical products, with a primary focus on specialty plasma-derived products for critical care, immunology, and hematology, leveraging its expertise in protein separation and purification to address unmet medical needs.
The headquarters serves as the central hub for Kamada's global operations, encompassing corporate management, research and development (R&D), and the primary manufacturing facility for its plasma-derived biopharmaceutical products.
Located in the Weizmann Science Park, a prestigious center for scientific research and high-tech industries in Israel. The facility includes state-of-the-art manufacturing suites compliant with international Current Good Manufacturing Practices (cGMP) standards.
Kamada promotes a collaborative, scientifically-driven, and innovative work environment focused on excellence and improving patient outcomes. The culture values teamwork, ethical practices, and continuous professional development, characteristic of a biopharmaceutical company dedicated to R&D and specialized manufacturing.
The Ness Ziona headquarters is paramount to Kamada's operations, housing its main manufacturing facility, advanced R&D laboratories, and corporate offices. This integration allows for streamlined development, production, and strategic oversight of its global biopharmaceutical business.
Kamada maintains a significant global presence, supporting functions such as research and development, cGMP-compliant manufacturing (primarily in Israel), clinical trial operations, global regulatory affairs, and worldwide commercial activities. While its core R&D and manufacturing are centralized in Israel, Kamada markets its products in over 30 countries. This is achieved through a direct sales force and commercial operations in the U.S., and an extensive network of strategic partners and distributors across Europe, Latin America, Asia, and other international markets.
2 Sapir St., Science Park, P.O. Box 4081
Ness Ziona
Central District
Israel
Address: 1 Maynard Drive, Suite 2102, Park Ridge, NJ 07656
To manage and expand Kamada's commercial footprint and product availability in the North American market, including engagement with healthcare providers, patient organizations, payers, and U.S. regulatory authorities.
Address: Various locations, e.g., Kamada Plasma, 9901 S Main St, Houston, TX 77025 (example of one center)
To ensure a consistent, high-quality supply of human plasma for Kamada's manufacturing processes, supporting the company's vertical integration strategy and bolstering its supply chain security for critical medicines.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, KAMADA' leadership includes:
KAMADA has been backed by several prominent investors over the years, including:
Kamada strengthened its executive leadership with the appointment of Dr. Michal Ayalon as Vice President, Global Regulatory Affairs in late 2023. No other major high-level executive hires or departures were prominently announced in the publicly available records over the last 12 months (Approx. May 2023 - May 2024).
Discover the tools KAMADA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Kamada Ltd. likely employs standard corporate email address formats. Common patterns observed for companies of its nature and in its industry include using the employee's first initial followed by their last name, or the first name and last name separated by a period. All email addresses would use the '@kamada.com' domain.
[first_initial][last]@kamada.com (e.g., jdoe@kamada.com) or [first].[last]@kamada.com (e.g., jane.doe@kamada.com)
Format
alondon@kamada.com (example for Amir London, using first initial last name format)
Example
75%
Success rate
GlobeNewswire via Yahoo Finance • May 9, 2024
Kamada announced its financial results for the first quarter of 2024, reporting total revenues of $30.2 million. The company emphasized strong sales growth for KEDRAB® and ongoing advancements in its portfolio of immunoglobulin products....more
GlobeNewswire via Kamada Official Website • April 2, 2024
Kamada received approval from the U.S. Food and Drug Administration (FDA) for a new, ready-to-use liquid formulation of CYTOGAM® (Cytomegalovirus Immune Globulin Intravenous [Human]). This formulation offers enhanced convenience for healthcare providers and is used for the prophylaxis of cytomegalovirus disease associated with transplantation....more
GlobeNewswire via Kamada Official Website • February 29, 2024
Kamada announced that positive results from a Phase 2 clinical trial of its investigational anti-CD20 monoclonal antibody were published in the peer-reviewed journal 'Transplantation and Cellular Therapy'. The study demonstrated promising efficacy and safety data for the antibody in the treatment of chronic Graft-Versus-Host Disease (cGvHD)....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including KAMADA, are just a search away.